Cellebrite Shares Drop After 1Q Revenue Miss

Dow Jones
2025/05/14
 

By Chris Wack

 

Cellebrite shares were down 7% to $18.71 after the company reported first-quarter revenue that was below analysts' expectations.

The technology company said it had quarterly revenue of $107.5 million, compared to $89.6 million in the same quarter last year. Analysts polled by FactSet were looking for revenue of $109.3 million.

The company swung to a profit this quarter, seeing earnings of $17.4 million, or 7 cents a share, compared with a loss of $71.4 million, or 36 cents a share, last year. Analysts were expecting earnings of $11.6 million, or 5 cents a share.

Adjusted earnings were 10 cents a share, compared with the 7 cents a share analysts had forecast.

Cellebrite said its subscription revenue was $95.8 million in the first quarter, up 21% year-over-year, and annual recurring revenue was $408 million, up 23% year-over-year.

The company is expecting quarterly revenue of $110 million to $116 million, compared with the $115.3 million analysts are looking for. For 2025, Cellebrite is looking for revenue of $470 million to $485 million, while analysts are forecasting 2025 revenue of $484.2 million.

Cellebrite said its outlook for the second quarter reflects its expectation that the current U.S. Federal spending environment will persist into the second quarter. Its 2025 revenue target now reflects the timing of net new business in the second half of its year, combined with lower anticipated one-time professional services revenue from the U.S. Federal vertical.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

May 14, 2025 10:41 ET (14:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10